Sunday, May 01, 2016 11:45:31 PM
This company will behave more like a call option on a one drug bio tech that has to get through the first level of FDA approval
Realize, the company is worth zero if the PTAB says the patent are invalid, and worth a great deal if they say the patents are valid.
Sentiment has said, no one trusts the ptab, so until they rule, very few real market players are getting in here.
Add in the fact that downward pressure recently has nothing to do with sentiment and more with a convert holder selling, charts mean little.
Charting a 2 cent stock whose value will be solely predicated on how the PTAB rules is pointless. No one can 'accruately predict' that - thus the market is assuming unless they rule in our favor this is pretty much just a lotto ticket / call option with the only value being 'theta' or time value at this stage. If theta runs out (ie PTAB rules against us), the value will be zero
Recent WDDD News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 08:47:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 12:00:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 09:30:21 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 06:34:14 PM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM